Showing results (31-40 of 104) with videos related to

Sort By:
Pageof 11
Analytical Cellular Pathology (Amsterdam)|September 24, 2016
Predictive and Prognostic Value of sPRR in Patients with Primary Epithelial Ovarian CancerKatrin Kreienbring, Annika Franz, Rolf Richter, et al.
Journal of the American Society of Hypertension : JASH|October 21, 2017
Soluble (pro)renin receptor in preeclampsia and diabetic pregnanciesMeryam Sugulle, Harald Heidecke, Ulrike Maschke, et al.
Brain, Behavior, & Immunity - Health|September 30, 2021
IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFSJelka Hartwig, Franziska Sotzny, Sandra Bauer, et al.
Anticancer Research|June 1, 2018
The Role of PAR1 Autoantibodies in Patients with Primary Epithelial Ovarian CancerKatrin Kreienbring, Annika Franz, Rolf Richter, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Vitronectin concentrations predict risk in patients undergoing coronary stentingWolfgang Derer, Elliot S Barnathan, Erdal Safak, et al.
Frontiers in Immunology|April 7, 2018
Autoantibodies in Serum of Systemic Scleroderma Patients: Peptide-Based Epitope Mapping Indicates Increased Binding to Cytoplasmic Domains of CXCR3Andreas Recke, Ann-Katrin Regensburger, Florian Weigold, et al.
Scientific Reports|October 12, 2019
Lowered anti-beta1 adrenergic receptor antibody concentrations may have prognostic significance in acute coronary syndromeDiana Ernst, Johan Westerbergh, Georgios Sogkas, et al.
Journal of Clinical Medicine|September 13, 2025
The Influence of Anti-C3aR and Anti-C5aR Antibody Levels on the Course of Specific Glomerulonephritis TypesMaciej Szymczak, Harald Heidecke, Marcelina Żabińska, et al.
Journal of Clinical Medicine|May 14, 2025
The Influence of Anti-PAR 1 and Anti-ACE 2 Antibody Levels on the Course of Specific Glomerulonephritis TypesMaciej Szymczak, Harald Heidecke, Marcelina Żabińska, et al.
Pageof 11